Literature DB >> 16394433

Post-kala-azar dermal leishmaniasis: a histopathological study.

Sanjay K Rathi1, R K Pandhi, P Chopra, N Khanna.   

Abstract

BACKGROUND: Post-kala-azar dermal leishmaniasis follows an attack of visceral leishmaniasis and is caused by the same organism, i.e. Leishmania donovani.
METHODS: In the present study, biopsy specimens from hypopigmented macules, nodules or plaques of 25 patients clinically diagnosed as PKDL were evaluated for epidermal and dermal changes and for the presence or absence of Leishmania donovani bodies (LDBs).
RESULTS: The hypopigmented macules showed a patchy perivascular and periappendageal infiltrate with no demonstrable LDBs in any of the biopsies. In the nodular and plaque lesions, the infiltrate was diffuse, beneath an atrophic epidermis (74%) and follicular plugging (95.6%) was seen in most biopsies. The infiltrate consisted of lymphocytes, histiocytes and plasma cells in decreasing order of presence. LDBs could be demonstrated in only 10 (43.5%) biopsy specimens from nodular and plaque lesions and were never numerous.
CONCLUSIONS: Histopathological features of PKDL are elucidated and discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16394433     DOI: 10.4103/0378-6323.16616

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  11 in total

Review 1.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

2.  Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis.

Authors:  Sankha Koley; Rajesh Kumar Mandal; Sanjiv Choudhary; Arghya Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

Review 3.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

4.  Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients.

Authors:  Gajendra Kumar Katara; Nasim Akhtar Ansari; Sandeep Verma; V Ramesh; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

5.  Skin as a marker of internal disease: a case of sarcoidosis.

Authors:  Manjyot Gautam; Sharmila Patil; Pritam Munde
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

Review 6.  Post kala-azar dermal leishmaniasis: an unresolved mystery.

Authors:  Debanjan Mukhopadhyay; Jane E Dalton; Paul M Kaye; Mitali Chatterjee
Journal:  Trends Parasitol       Date:  2014-01-02

Review 7.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

Review 8.  Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.

Authors:  Maria Angela Bianconcini Trindade; Lana Luiza da Cruz Silva; Lucia Maria Almeida Braz; Valdir Sabbaga Amato; Bernard Naafs; Mirian Nacagami Sotto
Journal:  BMC Infect Dis       Date:  2015-11-23       Impact factor: 3.090

9.  Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.

Authors:  V Ramesh; Ruchi Singh; Kumar Avishek; Aditya Verma; Deepak Kumar Deep; Sandeep Verma; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2015-10-22

10.  In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.

Authors:  Ritika Sengupta; Shibabrata Mukherjee; Srija Moulik; Sneha Mitra; Surya Jyati Chaudhuri; Nilay Kanti Das; Uttara Chatterjee; Mitali Chatterjee
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-08-22       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.